A dangerous environmental fungus appears to have settled into Nova Scotia

Cryptococcus gattii is an environmental fungus that can cause severe brain and lung disease in otherwise healthy people, and it is not supposed to be a feature of life in Atlantic Canada. A review published in the US Centers for Disease Control and Prevention journal Emerging Infectious Diseases now suggests it has quietly established itself there: of six confirmed infections in Nova Scotia during 2016–2024, five were a single genotype concentrated in the west of the province, and four of those occurred in people who had never travelled outside Nova Scotia [s1].

The distinction between an imported case and a locally acquired one is the whole point. C. gattii lives in soil and on trees, and people are infected by inhaling it, not by catching it from one another. If patients who never left the province are turning up with the same regional strain, the fungus is in the local environment — a shift from occasional traveller's illness to home-grown endemic risk [s1].

Six cases, carefully confirmed

Because C. gattii was not a notifiable disease in Nova Scotia during the study period, the investigators had to find cases retrospectively, working through laboratory and clinical records with help from infectious-diseases physicians [s1]. They classified six infections as confirmed C. gattii under the province's communicable-disease surveillance guidelines, identifying the cultured isolates by mass spectrometry and sending them to the British Columbia Centre for Disease Control's public health laboratory for molecular typing [s1]. Three further patients who tested positive for cryptococcal antigen were excluded because the species could not be confirmed, which means the six are a firmly identified floor rather than the full count [s1].

The geography and genetics line up in a way that points inward. Five of the six cases were in the province's Western Zone and one in the Eastern Zone [s1]. All five Western Zone isolates were genotype VGIIb — the subtype associated with severe disease — and four of those patients reported no travel outside Nova Scotia; the fifth had travelled to British Columbia, where C. gattii is already endemic [s1]. The lone Eastern Zone isolate was a different genotype, VGI, in a patient who had previously lived in South Africa, where VGI circulates, so that case's source of acquisition remains uncertain [s1].

An old spread finally reaching the Atlantic coast

The finding fits a longer Canadian trajectory. C. gattii emerged in British Columbia after a 1999 outbreak on Vancouver Island and then became endemic there [s1]. Two human infections were reported in Quebec, in 2008 and 2015, in people who had not travelled outside the province, though the sources were never identified [s1]. And in 2014, a VGIIb-like strain was found in a free-ranging white-tailed deer in Nova Scotia — an early hint that the fungus was already present in the Atlantic environment, which the new human cases now reinforce [s1]. The authors read the clustering of locally acquired VGIIb infections, together with that earlier animal detection, as evidence of regional endemicity rather than a run of unrelated imports [s1].

The clinical picture underlines why this matters beyond the laboratory. All six patients had disease involving the central nervous system, and two also had lung involvement [s1]. Five were presumed to have normal immune systems — consistent with C. gattii's reputation for striking the immunocompetent, unlike many fungal infections that prey on weakened immunity [s1]. All six were admitted to hospital, one needed intensive care, and one died [s1]. The fungus is also slow to declare itself: its incubation typically runs 2 to 11 months and can stretch to years, which both complicates tracing a case back to a local exposure and means early infections can be easy to miss [s1].

The case for watching

The practical takeaway is about recognition. A pathogen that is not notifiable, that incubates for months, and that can sicken healthy people is one clinicians may not think to test for in a region where it was assumed to be absent [s1]. The authors' retrospective hunt turned up six confirmed cases and three more probable ones precisely because no system was routinely looking. Establishing that C. gattii is locally acquired in western Nova Scotia is the argument for changing that — for keeping the fungus on the differential diagnosis for unexplained meningitis or lung disease in the area, and for the environmental and surveillance work that would map how far it has spread. The six patients are a small number, but endemic establishment is measured by where a pathogen is acquired, not yet by how many it has reached.